Synermore Biologics, United States
Dr. Eric Tsao is the CEO and founder of Synermore Biologics, established in 2013. With a background that includes roles at MedImmune and Aeras, he brings extensive experience in biotechnology. Under his leadership, Synermore focuses on developing both innovative and biosimilar products, particularly monoclonal antibodies and other biologics. The company operates internationally, with R&D headquartered in Taipei and additional assets in China, employing around 90 experts.
Oral Presentation (In-Person)
